References
- Gaugler-Senden IP, Huijssoon AG, Visser W, et al. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks’ gestation. Audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol 2006;128:216–21
- Olusanya BO, Solanke OA. Perinatal outcomes associated with maternal hypertensive disorders of pregnancy in a developing country. Hypertens Pregn 2012;31:120–30
- Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997--2008. BMC Pregn Childbirth 2012;12:47
- Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010;5:173–92
- Espinoza J. Effect of terminated fetal circulation on maternal angiogenic factors in severe early preeclampsia. Hypertens Pregn 2013;32:94–5
- Shear RM, Rinfret D, Leduc L. Should we offer expectant management in cases of severe preeclampsia with fetal growth restriction? Am J Obstet Gynecol 2005;192:1119–25
- American College of Obstetricians and Gynocologists. ACOG practice bulletin no.33, January 2002. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99:159–67
- Korst LM, Fridman M, Lu MC, et al. Trending elective preterm deliveries using administrative data. Paediatr Perinat Epidemiol 2013;27:44–53
- Ananth CV, Vintzileos AM. Maternal-fetal conditions necedditating a medical intervention resulting in preterm birth. Am J Obstet Gynecol 2006;195:1557–63
- Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005
- Nevo O, Many A, Xu J, et al. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2008;93:285–92
- Yinon Y, Nevo O, Xu J, et al. Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3. Am J Pathol 2008;172:77–85
- Burton GJ, Yung HW, Cindrova-Davies T, et al. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009;30:S43–8
- Shear RM, Rinfret D, Leduc L. Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction? Am J Obstet Gynecol 2005;192:1119–25
- Pallasmaa N, Ekblad U, Aitokallio-Tallberg A, et al. Cesarean delivery in Finland: maternal complications and obstetric risk factors. Acta Obstet Gynecol Scand 2010;89:896–902
- Melchiorre K, Sutherland GR, Baltabaeva A, et al. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension 2011;57:85–93
- Tranquilli AL, Landi B, Giannubilo SR, et al. Preeclampsia: no longer solely a pregnancy disease. Hypertension 2012;2:350–7
- Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010;56:166–71
- Heidrich MB, Wenzel D, von Kaisenberg CS, et al. Preeclampsia and long-term risk of cardiovascular disease: what do obstetrician-gynecologists know? BMC Pregn Childbirth 2013;13:61